+ All Categories
Home > Documents > Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Date post: 14-Jan-2016
Category:
Upload: milt
View: 53 times
Download: 0 times
Share this document with a friend
Description:
Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study. Dennis J. Murphy, PhD, DABT Director - Safety Pharmacology US GlaxoSmithKline Pharmaceuticals. Advantages. - PowerPoint PPT Presentation
3
Advantages of Conducting a Stand- Alone Respiratory Safety Pharmacology Study Dennis J. Murphy, PhD, DABT Director - Safety Pharmacology US GlaxoSmithKline Pharmaceuticals
Transcript
Page 1: Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Dennis J. Murphy, PhD, DABT

Director - Safety Pharmacology US

GlaxoSmithKline Pharmaceuticals

Page 2: Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Advantages Ventilatory measurements in animal models can be highly variable due

primarily to a sensitivity to environmental changes (stimuli)– Stimuli include noise, odor, movement, handling, light, temperature– As such, measurements require a highly controlled environment for

accurate and repeatable measurements This can be achieved in a stand-alone study Very difficult to achieve in a typical toxicology study where many activities are

constantly ongoing and high number of animals are involved

Stand-alone studies allow the use of animals with a telemetry implant for measuring body temperature and pleural pressure (required to obtain a direct measure of airway resistance)

– Generally not acceptable in a toxicology study due to pathology complications and resource limitations

Page 3: Advantages of Conducting a Stand-Alone Respiratory Safety Pharmacology Study

Advantages (continued) Stand-alone studies have greater flexibility in study design

– Can use either crossover designs (animals serve as their own control) or parallel design with n = 6-8 of single sex per dose group

– Can include recovery time for assessing reversibility or delayed effects (beyond 24 hrs post dose)

– A typical 2/4 week toxicology study can be limited to a parallel design with n=3/sex per dose group (non-rodent) (sufficient for statistical analysis?) and may not include a recovery period (rodent or non-rodent)

Acute (day 1) measurements can be obtained with stand-alone studies– Day 1 measurements are critical because of tachyphylaxis or

tolerance/compensation that can develop on repeat dosing– This can be difficult in toxicology studies because of TK analysis and

enhanced clinical observations that need to be conducted on day1


Recommended